Skip to main content

and
Your search also matched 13 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Safety Findings in Lasmiditan as a Novel Acute Treatment of Migraine in Chinese Patients: A Post Hoc Analysis of the Randomized Controlled Phase 3 CENTURION Trial

Include preview-only content
  1. Article

    Open Access

    The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma

    Marital status has been reported to influence the survival outcomes of various cancers, but its impact on patients with mantle cell lymphoma (MCL) remains unclear. This study aimed to assess the influence of m...

    Ting Zhang, Zhao-tong Wang, Zhuo Li in Journal of Cancer Research and Clinical On… (2024)

  2. Article

    Open Access

    Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy

    BET proteins, which influence gene expression and contribute to the development of cancer, are epigenetic interpreters. Thus, BET inhibitors represent a novel form of epigenetic anticancer treatment. Although ...

    Zhi-Qiang Wang, Zhao-Cong Zhang, Yu-Yang Wu in Signal Transduction and Targeted Therapy (2023)

  3. Article

    Open Access

    Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

    EMERGING-CTONG 1103 showed improved progression-free survival (PFS) with neoadjuvant erlotinib vs. chemotherapy for patients harbouring EGFR sensibility mutations and R0 resected stage IIIA-N2 non-small cell l...

    Wen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen in Signal Transduction and Targeted Therapy (2023)

  4. Article

    Open Access

    Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis

    Despite limited efficacy of immunotherapy for advanced non-small-cell lung cancer (NSCLC) with driver mutations, whether neoadjuvant immunotherapy could be clinically valuable in those patients warrants furthe...

    Chao Zhang, Hua-Fei Chen, Shi Yan, Lin Wu, Li-Xu Yan in npj Precision Oncology (2022)

  5. Article

    Open Access

    SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl accumulation in respiratory epithelium

    SARS-CoV-2, the culprit pathogen of COVID-19, elicits prominent immune responses and cytokine storms. Intracellular Cl is a crucial regulator of host defense, whereas the role of Cl signaling pathway in modulat...

    Lei Chen, Wei-Jie Guan, Zhuo-Er Qiu in Signal Transduction and Targeted Therapy (2022)